scPharmaceuticals Inc.

3.29
0.06 (1.86%)
At close: Jan 28, 2025, 3:36 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -54.81M -36.84M -28.03M -32.21M -33.00M -29.44M -23.82M -24.38M -10.52M
Depreciation & Amortization 626.00K 468.00K 438.00K 399.00K 364.00K 332.00K 167.00K 5.00K 4.00K
Stock-Based Compensation 4.86M 2.84M 2.37M 2.00M 1.45M 2.13M 947.00K 876.00K 379.00K
Other Working Capital 221.00K -887.00K -234.00K 236.00K -611.00K -833.00K -1.13M -214.00K -85.00K
Other Non-Cash Items -3.60M -695.00K 678.00K 639.00K 385.00K 374.00K 198.00K 6.51M -394.00K
Deferred Income Tax n/a n/a n/a 30.00K 2.00K n/a n/a n/a n/a
Change in Working Capital -6.32M -350.00K -2.60M 1.45M 354.00K -2.21M -177.00K 1.53M 889.00K
Operating Cash Flow -59.24M -34.58M -27.15M -27.69M -30.44M -28.81M -22.68M -15.46M -9.64M
Capital Expenditures -40.00K -21.00K -9.00K n/a n/a n/a -194.00K -9.00K -17.00K
Acquisitions n/a 45.84M -32.14M n/a n/a n/a n/a n/a n/a
Purchase of Investments -50.59M -67.54M -9.01M -72.16M n/a n/a n/a n/a n/a
Sales Maturities Of Investments 70.60M 21.70M 41.15M 38.70M n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -45.84M 32.14M -33.46M n/a n/a n/a n/a n/a
Investing Cash Flow 19.96M -45.86M 32.13M -33.46M n/a n/a -194.00K -9.00K -17.00K
Debt Repayment n/a 29.80M -2.50M n/a 9.55M -62.00K 9.27M 12.60M n/a
Common Stock Repurchased n/a n/a -81.00K -164.00K n/a -4.00K -3.00K n/a -9.00K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 812.00K -337.00K -81.00K -228.00K 60.00K 58.00K 94.00K 40.57M 8.03M
Financial Cash Flow 14.85M 77.23M -2.53M 60.35M 13.59M -8.00K 102.07M 53.17M 8.02M
Net Cash Flow -24.43M -3.21M 2.45M -805.00K -16.85M -28.82M 79.20M 37.71M -1.64M
Free Cash Flow -59.28M -34.60M -27.16M -27.69M -30.44M -28.81M -22.88M -15.46M -9.66M